FDA Inspection 1321654 — Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited)
The FDA completed an inspection of Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited) on May 8, 2026 in Gurugram. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 8, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gurugram (India)